Literature DB >> 6994766

Haemodynamic effects of guanfacine.

D Magometschnigg, G Hitzenberger, J Bonelli.   

Abstract

1. The haemodynamic mechanism of action of guanfacine 4 mg intravenously was investigated in resting conditions and during exercise for up to 20 h after administration of the drug. Cardiac output and pulmonary arterial pressure were determined by the Swan-Ganz thermodilution method. Blood pressure was measured directly. 2. During and immediately after intravenous administration of guanfacine, blood pressure peripheral resistance and pulmonary arterial pressure increased (in keeping with an alpha-sympathomimetic effect of the compound), whereas heart rate and cardiac output decreased. 3. Subsequently blood pressure fell as a result of a decrease in cardiac output. From the third hour peripheral resistance decreased, whereas cardiac output increased again, sometimes exceeding the control value. 4. During exercise blood pressure was reduced from the third hour after administration, as in resting conditions, as a result of the reduction in peripheral resistance. 5. In resting conditions guanfacine reduced heart rate at the beginning and during the whole course after administration of the drug. 6. Side-effects noted included fatigue, drowsiness and bradycardia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994766      PMCID: PMC1430134          DOI: 10.1111/j.1365-2125.1980.tb04919.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  [Guanfacinum (BS 100-14) in long-term therapy of severe hypertension].

Authors:  A Röckel; B Sabel; A Heidland
Journal:  Verh Dtsch Ges Inn Med       Date:  1977 Apr 17-21

2.  A new centrally action antihypertensive agent guanfacine (BS 100-141).

Authors:  U C Dubach; R Huwyler; P Radielovic; M Singeisen
Journal:  Arzneimittelforschung       Date:  1977

3.  [Clinical function test of the heart].

Authors:  A Bühlmann
Journal:  Schweiz Med Wochenschr       Date:  1965-10-02

4.  [First experiences with BS 100-141, a new antihypertensive substance].

Authors:  I Esch
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-09

5.  Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.

Authors:  W Kirch; A Distler
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-03
  5 in total
  2 in total

Review 1.  Central sympatholytic drugs.

Authors:  Wanpen Vongpatanasin; Kazuomi Kario; Steven A Atlas; Ronald G Victor
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-18       Impact factor: 3.738

Review 2.  Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.